玻璃体-话题@MedSci

#玻璃体#

58篇内容 | 2118人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1496247, encodeId=3820149624e75, content=<a href='/topic/show?id=bab46858ee3' target=_blank style='color:#2F92EE;'>#玻璃体#</a>, objectTitle=JAMA Ophthalmol：玻璃体内注射VEGF抑制剂阿柏西普对糖尿病视网膜病变视力减退的预防作用, objectType=article, longId=209409, objectId=ebae2094096b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebae2094096b, replyNumber=0, likeNumber=86, createdTime=2021-04-05, rootId=0, userName=yykkxiaodou, userId=47bd9248134, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebae2094096b, moduleTitle=JAMA Ophthalmol：玻璃体内注射VEGF抑制剂阿柏西普对糖尿病视网膜病变视力减退的预防作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebae2094096b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496246, encodeId=4580149624652, content=<a href='/topic/show?id=bab46858ee3' target=_blank style='color:#2F92EE;'>#玻璃体#</a>, objectTitle=JAMA：阿帕西普vs手术治疗增生性糖尿病视网膜病变导致的玻璃体出血视力损伤, objectType=article, longId=204674, objectId=c67a2046e4db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c67a2046e4db, replyNumber=0, likeNumber=0, createdTime=2020-12-21, rootId=0, userName=yykkxiaodou, userId=47bd9248134, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c67a2046e4db, moduleTitle=JAMA：阿帕西普vs手术治疗增生性糖尿病视网膜病变导致的玻璃体出血视力损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c67a2046e4db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496245, encodeId=571914962459d, content=<a href='/topic/show?id=bab46858ee3' target=_blank style='color:#2F92EE;'>#玻璃体#</a>, objectTitle=FDA授予大麻素PPP003（HU308）预防增生性玻璃体视网膜病变的孤儿药称号, objectType=article, longId=192387, objectId=090819238ed1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=090819238ed1, replyNumber=0, likeNumber=84, createdTime=2020-04-18, rootId=0, userName=yykkxiaodou, userId=47bd9248134, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=090819238ed1, moduleTitle=FDA授予大麻素PPP003（HU308）预防增生性玻璃体视网膜病变的孤儿药称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=090819238ed1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496244, encodeId=15e614962446d, content=<a href='/topic/show?id=bab46858ee3' target=_blank style='color:#2F92EE;'>#玻璃体#</a>, objectTitle=Neurology：玻璃体视乳头牵引所致假性视盘水肿, objectType=article, longId=176266, objectId=bd281e626679, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd281e626679, replyNumber=0, likeNumber=96, createdTime=2019-07-28, rootId=0, userName=yykkxiaodou, userId=47bd9248134, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd281e626679, moduleTitle=Neurology：玻璃体视乳头牵引所致假性视盘水肿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd281e626679)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496243, encodeId=7fa01496243de, content=<a href='/topic/show?id=bab46858ee3' target=_blank style='color:#2F92EE;'>#玻璃体#</a>, objectTitle=BMC Ophthalmol：玻璃体内注射Ranibizumab后出现人疱疹病毒-6相关的角膜内皮炎并发症, objectType=article, longId=160214, objectId=cdeb160214fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cdeb160214fa, replyNumber=0, likeNumber=64, createdTime=2019-02-18, rootId=0, userName=yykkxiaodou, userId=47bd9248134, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cdeb160214fa, moduleTitle=BMC Ophthalmol：玻璃体内注射Ranibizumab后出现人疱疹病毒-6相关的角膜内皮炎并发症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cdeb160214fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496242, encodeId=cc0c149624255, content=<a href='/topic/show?id=bab46858ee3' target=_blank style='color:#2F92EE;'>#玻璃体#</a>, objectTitle=玻璃体内注射技术规范——2018 年欧洲视网膜专家学会共识解读, objectType=article, longId=157503, objectId=8f8415e503af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f8415e503af, replyNumber=0, likeNumber=75, createdTime=2019-01-08, rootId=0, userName=yykkxiaodou, userId=47bd9248134, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f8415e503af, moduleTitle=玻璃体内注射技术规范——2018 年欧洲视网膜专家学会共识解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f8415e503af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496241, encodeId=bceb1496241fb, content=<a href='/topic/show?id=bab46858ee3' target=_blank style='color:#2F92EE;'>#玻璃体#</a>, objectTitle=Int Med Case Rep J：玻璃体切除术后伴有息肉状脉络膜血管病继发的视网膜下出血而引起的交感眼炎病例, objectType=article, longId=155714, objectId=013e155e1434, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=013e155e1434, replyNumber=0, likeNumber=81, createdTime=2018-12-14, rootId=0, userName=yykkxiaodou, userId=47bd9248134, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=013e155e1434, moduleTitle=Int Med Case Rep J：玻璃体切除术后伴有息肉状脉络膜血管病继发的视网膜下出血而引起的交感眼炎病例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=013e155e1434)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496240, encodeId=e5c6149624095, content=<a href='/topic/show?id=bab46858ee3' target=_blank style='color:#2F92EE;'>#玻璃体#</a>, objectTitle=Eur J Ophthalmol：玻璃体内注射超低剂量雷珠单抗治疗早产1型视网膜病变的疗效, objectType=article, longId=153884, objectId=507c153884ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=507c153884ca, replyNumber=0, likeNumber=108, createdTime=2018-11-20, rootId=0, userName=yykkxiaodou, userId=47bd9248134, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=507c153884ca, moduleTitle=Eur J Ophthalmol：玻璃体内注射超低剂量雷珠单抗治疗早产1型视网膜病变的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=507c153884ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496239, encodeId=082e1496239f9, content=<a href='/topic/show?id=bab46858ee3' target=_blank style='color:#2F92EE;'>#玻璃体#</a>, objectTitle=Retina：25-GAUGE 玻璃体切除术术后低眼压发生率和危险因素研究, objectType=article, longId=152171, objectId=ec5a1521e19a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec5a1521e19a, replyNumber=0, likeNumber=91, createdTime=2018-10-30, rootId=0, userName=yykkxiaodou, userId=47bd9248134, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec5a1521e19a, moduleTitle=Retina：25-GAUGE 玻璃体切除术术后低眼压发生率和危险因素研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec5a1521e19a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496238, encodeId=8086149623858, content=<a href='/topic/show?id=bab46858ee3' target=_blank style='color:#2F92EE;'>#玻璃体#</a>, objectTitle=Ophthalmologica：玻璃体腔注射地塞米松治疗Behçet病患者黄斑囊样水肿疗效显著, objectType=article, longId=150777, objectId=e8a6150e7781, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8a6150e7781, replyNumber=0, likeNumber=0, createdTime=2018-10-12, rootId=0, userName=yykkxiaodou, userId=47bd9248134, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8a6150e7781, moduleTitle=Ophthalmologica：玻璃体腔注射地塞米松治疗Behçet病患者黄斑囊样水肿疗效显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8a6150e7781)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496237, encodeId=68c4149623e02, content=<a href='/topic/show?id=bab46858ee3' target=_blank style='color:#2F92EE;'>#玻璃体#</a>, objectTitle=Blood：泊马度胺联合地塞米松可有效治疗难治性/复发性原发性CNS或玻璃体视网膜淋巴瘤, objectType=article, longId=149948, objectId=038214994893, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=038214994893, replyNumber=0, likeNumber=88, createdTime=2018-09-30, rootId=0, userName=yykkxiaodou, userId=47bd9248134, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=038214994893, moduleTitle=Blood：泊马度胺联合地塞米松可有效治疗难治性/复发性原发性CNS或玻璃体视网膜淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=038214994893)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496236, encodeId=7f3014962369e, content=<a href='/topic/show?id=bab46858ee3' target=_blank style='color:#2F92EE;'>#玻璃体#</a>, objectTitle=PLoS One：向非肥胖糖尿病小鼠的玻璃体内注射促炎细胞因子建立糖尿病视网膜病变新模型, objectType=article, longId=147574, objectId=dd4f14e574ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd4f14e574ab, replyNumber=0, likeNumber=78, createdTime=2018-08-30, rootId=0, userName=yykkxiaodou, userId=47bd9248134, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd4f14e574ab, moduleTitle=PLoS One：向非肥胖糖尿病小鼠的玻璃体内注射促炎细胞因子建立糖尿病视网膜病变新模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd4f14e574ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496235, encodeId=a4101496235f1, content=<a href='/topic/show?id=bab46858ee3' target=_blank style='color:#2F92EE;'>#玻璃体#</a>, objectTitle=Retin Cases Brief Rep：小儿家族性渗出性玻璃体视网膜病变病例报告及治疗措施, objectType=article, longId=147557, objectId=a54814e557a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a54814e557a2, replyNumber=0, likeNumber=72, createdTime=2018-08-29, rootId=0, userName=yykkxiaodou, userId=47bd9248134, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a54814e557a2, moduleTitle=Retin Cases Brief Rep：小儿家族性渗出性玻璃体视网膜病变病例报告及治疗措施, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a54814e557a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496234, encodeId=421d1496234b7, content=<a href='/topic/show?id=bab46858ee3' target=_blank style='color:#2F92EE;'>#玻璃体#</a>, objectTitle=NEJM：星状玻璃体-病例报道, objectType=article, longId=147279, objectId=d3c114e279b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3c114e279b8, replyNumber=0, likeNumber=72, createdTime=2018-08-25, rootId=0, userName=yykkxiaodou, userId=47bd9248134, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3c114e279b8, moduleTitle=NEJM：星状玻璃体-病例报道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3c114e279b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496233, encodeId=c6d31496233ee, content=<a href='/topic/show?id=bab46858ee3' target=_blank style='color:#2F92EE;'>#玻璃体#</a>, objectTitle=Graefes Arch Clin Exp Ophthalmol：玻璃体内注射贝伐单抗治疗可减少早产儿视网膜病变中的眼部血流, objectType=article, longId=144470, objectId=03db1444e0a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03db1444e0a6, replyNumber=0, likeNumber=79, createdTime=2018-07-16, rootId=0, userName=yykkxiaodou, userId=47bd9248134, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03db1444e0a6, moduleTitle=Graefes Arch Clin Exp Ophthalmol：玻璃体内注射贝伐单抗治疗可减少早产儿视网膜病变中的眼部血流, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03db1444e0a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496232, encodeId=b8db149623237, content=<a href='/topic/show?id=bab46858ee3' target=_blank style='color:#2F92EE;'>#玻璃体#</a>, objectTitle=Free Radic Biol Med：细胞外超氧化物歧化酶3（SOD3）调节玻璃体视网膜界面的氧化应激反应, objectType=article, longId=142192, objectId=82e11421925d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82e11421925d, replyNumber=0, likeNumber=90, createdTime=2018-07-03, rootId=0, userName=yykkxiaodou, userId=47bd9248134, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82e11421925d, moduleTitle=Free Radic Biol Med：细胞外超氧化物歧化酶3（SOD3）调节玻璃体视网膜界面的氧化应激反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82e11421925d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496231, encodeId=61741496231c5, content=<a href='/topic/show?id=bab46858ee3' target=_blank style='color:#2F92EE;'>#玻璃体#</a>, objectTitle=Med Sci Monit：睫状环切口联合改良的玻璃体切除术治疗恶性青光眼的临床观察, objectType=article, longId=141017, objectId=4d8d14101e16, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d8d14101e16, replyNumber=0, likeNumber=77, createdTime=2018-06-20, rootId=0, userName=yykkxiaodou, userId=47bd9248134, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d8d14101e16, moduleTitle=Med Sci Monit：睫状环切口联合改良的玻璃体切除术治疗恶性青光眼的临床观察, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d8d14101e16)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496230, encodeId=0fa014962309e, content=<a href='/topic/show?id=bab46858ee3' target=_blank style='color:#2F92EE;'>#玻璃体#</a>, objectTitle=J Pediatr Hematol Oncol：质子束放射治疗对玻璃体种子视网膜母细胞瘤的治疗疗效, objectType=article, longId=137851, objectId=9f9813e85191, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f9813e85191, replyNumber=0, likeNumber=96, createdTime=2018-05-12, rootId=0, userName=yykkxiaodou, userId=47bd9248134, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f9813e85191, moduleTitle=J Pediatr Hematol Oncol：质子束放射治疗对玻璃体种子视网膜母细胞瘤的治疗疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f9813e85191)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496229, encodeId=18071496229ef, content=<a href='/topic/show?id=bab46858ee3' target=_blank style='color:#2F92EE;'>#玻璃体#</a>, objectTitle=2018 临床实践指南：玻璃体内注射抗血管内皮生长因子药物治疗眼部血管疾病, objectType=article, longId=137396, objectId=16d913e3966a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16d913e3966a, replyNumber=0, likeNumber=52, createdTime=2018-05-08, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16d913e3966a, moduleTitle=2018 临床实践指南：玻璃体内注射抗血管内皮生长因子药物治疗眼部血管疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16d913e3966a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1496228, encodeId=7b67149622894, content=<a href='/topic/show?id=bab46858ee3' target=_blank style='color:#2F92EE;'>#玻璃体#</a>, objectTitle=Retina ：平板玻璃体切除术术中结膜下抗生素对眼内炎的疗效, objectType=article, longId=136289, objectId=8608136289ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8608136289ea, replyNumber=0, likeNumber=99, createdTime=2018-04-25, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8608136289ea, moduleTitle=Retina ：平板玻璃体切除术术中结膜下抗生素对眼内炎的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8608136289ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

玻璃体

2020-05-29

yykkxiaodou (审核中...)

前往app查看评论内容

#玻璃体#

JAMA Ophthalmol：玻璃体内注射VEGF抑制剂阿柏西普对糖尿病视网膜病变视力减退的预防作用

2021-04-05

yykkxiaodou (审核中...)

前往app查看评论内容

#玻璃体#

JAMA：阿帕西普vs手术治疗增生性糖尿病视网膜病变导致的玻璃体出血视力损伤

2020-12-21

yykkxiaodou (审核中...)

前往app查看评论内容

#玻璃体#

FDA授予大麻素PPP003（HU308）预防增生性玻璃体视网膜病变的孤儿药称号

2020-04-18

yykkxiaodou (审核中...)

前往app查看评论内容

#玻璃体#

Neurology：玻璃体视乳头牵引所致假性视盘水肿

2019-07-28

yykkxiaodou (审核中...)

前往app查看评论内容

#玻璃体#

BMC Ophthalmol：玻璃体内注射Ranibizumab后出现人疱疹病毒-6相关的角膜内皮炎并发症

2019-02-18

yykkxiaodou (审核中...)

前往app查看评论内容

#玻璃体#

玻璃体内注射技术规范——2018 年欧洲视网膜专家学会共识解读

2019-01-08

yykkxiaodou (审核中...)

前往app查看评论内容

#玻璃体#

Int Med Case Rep J：玻璃体切除术后伴有息肉状脉络膜血管病继发的视网膜下出血而引起的交感眼炎病例

2018-12-14

yykkxiaodou (审核中...)

前往app查看评论内容

#玻璃体#

Eur J Ophthalmol：玻璃体内注射超低剂量雷珠单抗治疗早产1型视网膜病变的疗效

2018-11-20

yykkxiaodou (审核中...)

前往app查看评论内容

#玻璃体#

Retina：25-GAUGE 玻璃体切除术术后低眼压发生率和危险因素研究

2018-10-30

yykkxiaodou (审核中...)

前往app查看评论内容

#玻璃体#

Ophthalmologica：玻璃体腔注射地塞米松治疗Behçet病患者黄斑囊样水肿疗效显著

2018-10-12

yykkxiaodou (审核中...)

前往app查看评论内容

#玻璃体#

Blood：泊马度胺联合地塞米松可有效治疗难治性/复发性原发性CNS或玻璃体视网膜淋巴瘤

2018-09-30

yykkxiaodou (审核中...)

前往app查看评论内容

#玻璃体#

PLoS One：向非肥胖糖尿病小鼠的玻璃体内注射促炎细胞因子建立糖尿病视网膜病变新模型

2018-08-30

yykkxiaodou (审核中...)

前往app查看评论内容

#玻璃体#

Retin Cases Brief Rep：小儿家族性渗出性玻璃体视网膜病变病例报告及治疗措施

2018-08-29

yykkxiaodou (审核中...)

前往app查看评论内容

#玻璃体#

NEJM：星状玻璃体-病例报道

2018-08-25

yykkxiaodou (审核中...)

前往app查看评论内容

#玻璃体#

Graefes Arch Clin Exp Ophthalmol：玻璃体内注射贝伐单抗治疗可减少早产儿视网膜病变中的眼部血流

2018-07-16

yykkxiaodou (审核中...)

前往app查看评论内容

#玻璃体#

Free Radic Biol Med：细胞外超氧化物歧化酶3（SOD3）调节玻璃体视网膜界面的氧化应激反应

2018-07-03

yykkxiaodou (审核中...)

前往app查看评论内容

#玻璃体#

Med Sci Monit：睫状环切口联合改良的玻璃体切除术治疗恶性青光眼的临床观察

2018-06-20

yykkxiaodou (审核中...)

前往app查看评论内容

#玻璃体#

J Pediatr Hematol Oncol：质子束放射治疗对玻璃体种子视网膜母细胞瘤的治疗疗效

2018-05-12

爆笑小医 (审核中...)

前往app查看评论内容

#玻璃体#

2018 临床实践指南：玻璃体内注射抗血管内皮生长因子药物治疗眼部血管疾病

2018-05-08

爆笑小医 (审核中...)

前往app查看评论内容

#玻璃体#

Retina ：平板玻璃体切除术术中结膜下抗生素对眼内炎的疗效

2018-04-25

科室
- - 订阅+
  - 更多科室
工具
服务